A 37-year-old woman's colon cancer symptom was dismissed as part of pregnancy. Months later, she was diagnosed with stage 4.
Gabby Zappia, 37, experienced blood in her stool during her third pregnancy. Months after giving birth, she learned she had stage 4 colon cancer.
Gabby Zappia, 37, experienced blood in her stool during her third pregnancy. Months after giving birth, she learned she had stage 4 colon cancer. Thi
Read Full Story at Business Insider Mkt →Why This Matters
The dismissal of Gabby Zappia’s symptoms during pregnancy reflects a troubling pattern where maternal health concerns are deprioritized or misattributed, even when they signal life-threatening conditions. This case underscores how systemic gaps in medical education and patient advocacy can lead to devastating delays in diagnosis, particularly for women whose symptoms are too often minimized as hormonal or routine.
Background Context
Colorectal cancer rates among younger adults have been rising for decades, yet public health campaigns still focus predominantly on screening for those over 50. Meanwhile, pregnancy-related complaints—even red flags like rectal bleeding—are frequently dismissed as temporary or hormonal, delaying critical interventions. This disconnect is exacerbated by a lack of standardized protocols for evaluating gastrointestinal symptoms in pregnant patients.
What Happens Next
Zappia’s case may prompt advocacy groups to push for clearer guidelines on colorectal cancer screening in pregnant and postpartum women, particularly those with persistent symptoms. Healthcare systems could also face scrutiny over implicit biases that delay diagnosis in women, while insurers may face pressure to cover more comprehensive diagnostic testing for high-risk patients.
Bigger Picture
This story is part of a larger reckoning with how women’s health—especially reproductive health—is often sidelined in medical decision-making. As younger patients face rising rates of cancers typically associated with older demographics, the gap between symptom recognition and actionable care could become a defining challenge in public health policy.
